TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
2.260
+0.100 (4.63%)
Feb 2, 2026, 4:00 PM EST - Market closed
TherapeuticsMD Market Cap
TherapeuticsMD has a market cap or net worth of $26.16 million as of February 3, 2026. Its market cap has increased by 117.98% in one year.
Market Cap
26.16M
Enterprise Value
25.53M
1-Year Change
117.98%
Ranking
Category
Stock Price
$2.26
Market Cap Chart
Since April 23, 2013, TherapeuticsMD's market cap has decreased from $204.60M to $26.16M, a decrease of -87.22%. That is a compound annual growth rate of -14.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 26.20M | 38.62% |
| Dec 31, 2025 | 18.90M | 90.91% |
| Dec 31, 2024 | 9.90M | -58.40% |
| Dec 29, 2023 | 23.80M | -55.01% |
| Dec 30, 2022 | 52.90M | -64.99% |
| Dec 31, 2021 | 151.10M | -54.23% |
| Dec 31, 2020 | 330.10M | -49.70% |
| Dec 31, 2019 | 656.20M | -27.60% |
| Dec 31, 2018 | 906.30M | -30.67% |
| Dec 29, 2017 | 1.31B | 15.24% |
| Dec 30, 2016 | 1.13B | -38.50% |
| Dec 31, 2015 | 1.84B | 165.63% |
| Dec 31, 2014 | 694.30M | -8.08% |
| Dec 31, 2013 | 755.30M | 269.16% |
| Apr 23, 2013 | 204.60M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cumberland Pharmaceuticals | 57.73M |
| InterCure | 51.20M |
| Rockwell Medical | 44.92M |
| Zhengye Biotechnology Holding | 44.55M |
| Talphera | 40.88M |
| BioXcel Therapeutics | 34.55M |
| SCYNEXIS | 31.43M |
| Aytu BioPharma | 27.61M |